Cellulose acetate phthalate microparticles containing Vibrio cholerae: steps toward an oral cholera vaccine

References

• 64th World Health Assembly. Cholera: mechanism for control and prevention. A64/18. 2011
   Google Scholar
• Borde A, Larsson A, Holmgren J, Nygren E. Preparation and evaluation of a freeze-dried oral killed cholera vaccine formulation. Eur J Pharm Biopharm 2011;79:508–18
   PubMed Web of Science ®Google Scholar
• Ali M, Lopez AL, You YA, et al. The global burden of cholera. Bull World Health Organ 2012;90:209–18
   PubMed Web of Science ®Google Scholar
• Chaignat CL, Monti V. Use of oral cholera vaccine in complex emergencies: what next? Summary report of an expert meeting and recommendations of WHO. J Health Popul Nutr 2007;25:244–61
   PubMed Web of Science ®Google Scholar
• Munoz FM, Sheffield JS, Beigi RH, et al. Research on vaccines during pregnancy: protocol design and assessment of safety. Vaccine 2013;31:4274–9
   PubMed Web of Science ®Google Scholar
• Girard MP, Steele D, Chaignat C, Kieny MP. A review of vaccine research and development: human enteric infections. Vaccine 2006;24:2732–50
   PubMedGoogle Scholar
• Reed SG, Bertholet S, Coler RN, Friede M. New horizons in adjuvants for vaccine development. Trends Immunol 2009;1:23–32
   Web of Science ®Google Scholar
• Provenzano D, Kovac P, Wade WF. The ABCs (Antibody, B cells, and Carbohydrate epitopes) of cholera immunity: considerations for an improved vaccine. Microb Immunol 2006;50:899–927
   PubMed Web of Science ®Google Scholar
• Cole ET, Scott RA, Connor AL, et al. Enteric coated HPMC capsules designed to achieve intestinal targeting. Int J Pharm 2002;231:83–95
   PubMed Web of Science ®Google Scholar
• Körber M, Ciper M, Hoffart V, et al. Enteric polymers as acidifiers for the pH-independent sustained delivery of a weakly basic drug salt from coated pellets. Eur J Pharm Biopharm 2011;78:447–54
   PubMed Web of Science ®Google Scholar
• Raffin RP, Jornada DS, Ré MI, et al. Sodium pantoprazole-loaded enteric microparticles prepared by spray drying: effect of the scale of production and process validation. Int J Pharm 2006;328:10–18
   Web of Science ®Google Scholar
• Gharsallaoui A, Roudaut G, Chambin O, et al. Applications of spray-drying in microencapsulation of food ingredients: an overview. Food Res Int 2007;40:1107–21
   Web of Science ®Google Scholar
• Año G, Esquisabel A, Pastor M, et al. A new oral vaccine candidate based on the microencapsulation by spray-drying of inactivated Vibrio cholerae. Vaccine 2011;34:5758–64
   Web of Science ®Google Scholar
• Año López G, García Sánchez HM, Valmaseda Pérez T, et al. Antigenicity and immunogenicity of inactivated Vibrio cholerae strain. Biotech Apl 2003;20:9–13
   Google Scholar
• European Council. European Pharmacopoeia 7.0. Strasbourg: Council of Europe: European Directorate for the Quality of Medicines and Healthcare; 2010
   Google Scholar
• Pastor M, Esquisabel A, Talavera A, et al. An approach to a cold chain free oral cholera vaccine: in vitro and in vivo characterization of Vibrio cholerae gastro-resistant microparticles. Int J Pharm 2013;448:247–58
   PubMed Web of Science ®Google Scholar
• Salvador A, Igartua M, Hernández RM, Pedraz JL. Combination of immune stimulating adjuvants with poly (lactide-co-glycolide) microspheres enhances the immune response of vaccines. Vaccine 2012;30:589–96
   PubMed Web of Science ®Google Scholar
• López Y, Infante JF, Sifontes S, et al. Pharmacology and toxicology of an oral tablet whole cells inactivated cholera vaccine in Sprague Dawley rats. Vaccine 2011;29:3596–9
   PubMed Web of Science ®Google Scholar
• Grabovac V, Guggi D, Bernkop-Schnürch A. Comparison of the mucoadhesive properties of various polymers. Adv Drug Deliv Rev 2005;57:1713–23
   PubMed Web of Science ®Google Scholar
• Kolakovic R, Laaksonen T, Peltonen L, et al. Spray-dried nanofibrillar cellulose microparticles for sustained drug release. Int J Pharm 2012;430:47–55
   PubMed Web of Science ®Google Scholar
• Sansone F, Picerno P, Mencherini T, et al. Flavonoid microparticles by spray-drying: influence of enhancers of the dissolution rate on properties and stability. J Food Eng 2011;103:188–96
   Web of Science ®Google Scholar
• Benchabane S, Subirade M, Vandenberg GW. Production of BSA-loaded alginate microcapsules: influence of spray dryer parameters on the microcapsule and BSA release. J Microencapsul 2007;24:565–76
   PubMed Web of Science ®Google Scholar
• Uddin AN, Bejugam NK, Gayakwad SG, et al. Oral delivery of gastro-resistant microencapsulated typhoid vaccine. J Drug Targeting 2009;17:553–60
   PubMed Web of Science ®Google Scholar
• Hori M, Onishi H, Machida Y. Evaluation of Eudragit-coated chitosan microparticles as an oral immune delivery system. Int J Pharm 2005;297:223–34
   PubMed Web of Science ®Google Scholar
• Tabata Y, Inoue Y, Ikada Y. Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres. Vaccine 1996;14:1677–85
   PubMed Web of Science ®Google Scholar
• Giunchedi P, Conti B, Genta I, et al. Emulsion spray-drying for the preparation of albumin-loaded PLGA microspheres. Drug Dev Ind Pharm 2001;27:745–50
   PubMed Web of Science ®Google Scholar
• Yeh M, Liu Y, Chen J, Chiang C. Oral immunogenicity of the inactivated Vibrio cholerae whole-cell vaccine encapsulated in biodegradable microparticles. J Control Release 2002;82:237–47
   PubMed Web of Science ®Google Scholar
• Estevan M, Gamazo C, Grilló MJ, et al. Experiments on a sub-unit vaccine encapsulated in microparticles and its efficacy against Brucella melitensis in mice. Vaccine 2006;24:4179–87
   PubMed Web of Science ®Google Scholar
• Mata E, Igartua M, Patarroyo ME, et al. Enhancing immunogenicity to PLGA microparticulate systems by incorporation of alginate and RGD-modified alginate. Eur J Pharm Sci 2011;40:32–40
   Web of Science ®Google Scholar
• Bibby DC, Davies NM, Tucker IG. Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems. Int J Pharm 2000;197:1–11
   PubMed Web of Science ®Google Scholar
• Hendrikx LH, Schure R, Öztürk K, et al. Different IgG-subclass distributions after whole-cell and acellular pertussis infant primary vaccinations in healthy and pertussis infected children. Vaccine 2011;29:6874–80
   PubMed Web of Science ®Google Scholar
• Shamsuzzaman S, Ahmed T, Mannoor K, et al. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses. Vaccine 2009;27:1386–92
   Google Scholar
• Talavera A, Año G, Pino Y, et al. Formulation in tablets of a cholera whole cells inactivated vaccine candidate. Vaccine 2006;24:3381–7
   PubMed Web of Science ®Google Scholar
• Huebner RE, Nicol M, Mothupi R, et al. Dose response of CRM197 and tetanus toxoid-conjugated Haemophilus influenzae type b vaccines. Vaccine 2004;23:802–6
   PubMed Web of Science ®Google Scholar
• Treanor J, Keitel W, Belshe R, et al. Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults. Vaccine 2002;20:1099–105
   PubMed Web of Science ®Google Scholar
• Ahmed T, Arifuzzaman M, Lebens M, et al. CD4+ T-cell responses to an oral inactivated cholera vaccine in young children in a cholera endemic country and the enhancing effect of zinc supplementation. Vaccine 2009;28:422–9
   PubMed Web of Science ®Google Scholar